Ryan, Logan Mataraso, Samson Siefkas, Anna Pellegrini, Emily Barnes, Gina Green-Saxena, Abigail Hoffman, Jana Calvert, Jacob Das, Ritankar
Published in
Clinical and Applied Thrombosis/Hemostasis
Deep venous thrombosis (DVT) is associated with significant morbidity, mortality, and increased healthcare costs. Standard scoring systems for DVT risk stratification often provide insufficient stratification of hospitalized patients and are unable to accurately predict which inpatients are most likely to present with DVT. There is a continued need...
Wada, Hideo Shiraki, Katsuya Matsumoto, Takeshi Ohishi, Kohshi Shimpo, Hideto Sakano, Yumi Nishii, Hiroko Shimaoka, Motomu
Published in
Clinical and Applied Thrombosis/Hemostasis
The FVIII activity in patients treated with several extended half-life FVIII (EHL-FVIII) agents different when various activated partial thromboplastin time (APTT) reagents were used. The present study examined the difference in clot waveform analysis (CWA) findings and FVIII activity when various APTT reagents and CWA were used. The CWA including ...
Sadiq, Muhammed Wahhaab Ukrani, Ronika Devi Arif, Aiman Akbar, Inaara Altaf, Sadaf Moiz, Bushra
Published in
Clinical and Applied Thrombosis/Hemostasis
Venous thromboembolism (VTE) is a recognized complication of hospital stay in young patients in many developed countries, but such an information is largely unavailable from a low middle-income country (LMIC). This study aimed at identifying the frequency, risk factors, treatment options and outcome of deep venous thrombosis/pulmonary embolism (DVT...
Peng, Miao Yang, Shengli Li, Guiling Zhang, Tao Qin, Xiaojuan Shi, Chen Chang, Jian Chen, Mengni Chen, Chen Li, Bingjie
...
Published in
Clinical and Applied Thrombosis/Hemostasis
Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT) occurs more frequently in cancer patients than in the general population. A retrospective cross-sectional study was carried out in patients with solid tumor complicated with VTE admitted to the Cancer Center, Union Hospital, Tongji Medical College, Huazho...
Zhao, Yongqiang Hu, Yu Jin, Jie Zhao, Xielan Wang, Xuefeng Wu, Runhui Wu, Depei Yang, Renchi Yang, Feng’e Hu, Qun
...
Published in
Clinical and Applied Thrombosis/Hemostasis
Antihemophilic factor (recombinant) (rAHF; ADVATE®; Baxalta US Inc., a Takeda company, Lexington, MA, USA) is indicated for the treatment and prevention of bleeding in patients with hemophilia A. We aimed to assess the safety and efficacy of standard prophylaxis versus on-demand treatment with rAHF in previously treated Chinese patients with severe...
Wegrzyn, Gracelene Walborn, Amanda Rondina, Matthew Fareed, Jawed Hoppensteadt, Debra
Published in
Clinical and Applied Thrombosis/Hemostasis
Sepsis-associated disseminated intravascular coagulation (DIC) is related to marked hemostatic changes such as transient thrombocytopenia secondary to the endogenous activation and consumption of platelets. This study measured markers of platelet function in 103 adult ICU patients with clinically established sepsis-associated DIC to determine the b...
Wang, Shigang Griffith, Bartley P. Wu, Zhongjun J.
Published in
Clinical and Applied Thrombosis/Hemostasis
Mechanically assisted circulation (MAC) sustains the blood circulation in the body of a patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) or on ventricular assistance with a ventricular assist device (VAD) or on extracorporeal membrane oxygenation (ECMO) with a pump-oxygenator system. While MAC provides short-term (days to weeks...
Sarfraz, Azza Sarfraz, Zouina Razzack, Aminah Abdul Patel, Gaurav Sarfraz, Muzna
Published in
Clinical and Applied Thrombosis/Hemostasis
The novel coronavirus disease 2019 (COVID-19) predisposes patients to venous thromboembolism (VTE) due to risk factors, severe infection, and severe inflammatory responses. The objective is to determine the risk of developing VTE after corticosteroid administration during COVID-19 treatment. Using PRISMA reporting guidelines, a review was conducted...
Sadek, Michael Iqbal, Omer Siddiqui, Fakiha Till, Sean Mazariegos, Melissa Campbell, Edward Mudaliar, Kumaran Speiser, Jodi Bontekoe, Emily Kouta, Ahmed
...
Published in
Clinical and Applied Thrombosis/Hemostasis
Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are Severe Cutaneous Adverse Reactions (SCARS) characterized by fever and mucocutaneous lesions leading to necrosis and sloughing of the epidermis. Conjunctival lesions are reported in 85% of patients. The pathogenesis of SJS/TEN/SCARS is not completely understood. It is hypothesiz...
Bashir, Dalia A. Da, Qi Pradhan, Subhashree Sekhar, Nitin Valladolid, Christian Lam, Fong Guffey, Danielle Goldman, Jordana Desai, Moreshwar S. Cruz, Miguel A.
...
Published in
Clinical and Applied Thrombosis/Hemostasis
Hyperferritinemia is associated with poor outcomes in critically ill patients with sepsis, hemophagocytic lymphohistiocytosis (HLH), macrophage activation syndromes (MAS) and coronavirus disease 19 (COVID-19). Autopsies of hyperferritinemic patients that succumbed to either sepsis, HLH, MAS or COVID-19 have revealed disseminated microvascular throm...